We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.3B
AUM Growth
+$850M
Cap. Flow
+$795M
Cap. Flow %
34.54%
Top 10 Hldgs %
16.37%
Holding
602
New
223
Increased
122
Reduced
83
Closed
146

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$40.2M
2
AIV
Aimco
AIV
+$38.4M
3
DEI icon
Douglas Emmett
DEI
+$32.6M
4
BDN
Brandywine Realty Trust
BDN
+$28M
5
KRC icon
Kilroy Realty
KRC
+$25.3M

Top Sells

Rank Stock Value
1
MAC icon
Macerich
MAC
+$23.4M
2
SPG icon
Simon Property Group
SPG
+$22.4M
3
PGRE
Paramount Group
PGRE
+$21.1M
4
TFC icon
Truist Financial
TFC
+$18.9M
5
REG icon
Regency Centers
REG
+$17.9M

Sector Composition

Rank Sector Weight
1 Real Estate 23.49%
2 Financials 11.65%
3 Energy 8.84%
4 Consumer Discretionary 7.75%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LKFT
376
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$606K 0.03%
14,500
– –
GUID
377
DELISTED
Guidance Software, Inc.
GUID
$602K 0.03%
+140,000
New +$676K
ASC icon
378
Ardmore Shipping
ASC
$678M
$592K 0.03%
+70,000
New +$625K
OCRX
379
DELISTED
Ocera Therapeutics, Inc.
OCRX
$579K 0.03%
197,000
– –
TEVA icon
380
Teva Pharmaceuticals
TEVA
$35.9B
$562K 0.02%
10,500
-400
-4% -$23.5K
QTNT
381
DELISTED
Quotient Limited Ordinary Shares
QTNT
$528K 0.02%
+1,500
New +$612K
IBB icon
382
iShares Biotechnology ETF
IBB
$9.31B
$522K 0.02%
+6,000
New +$537K
KERX
383
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$518K 0.02%
111,000
– –
CRDF icon
384
Cardiff Oncology
CRDF
$64.3M
$512K 0.02%
1,528
– –
MZOR
385
DELISTED
Mazor Robotics Ltd.
MZOR
$508K 0.02%
40,825
-9,175
-18% -$94.6K
ADXS
386
DELISTED
Advaxis Inc
ADXS
$506K 0.02%
3,733
+333
+10% +$36.8K
ALNY icon
387
Alnylam Pharmaceuticals
ALNY
$36.3B
$502K 0.02%
8,000
-1,000
-11% -$66.5K
PETX
388
DELISTED
Aratana Therapeutics, Inc.
PETX
$502K 0.02%
91,000
– –
SPLS
389
CALL
DELISTED
Staples Inc
SPLS
$496K 0.02%
45,000
-218,200
-83% -$2.05M
STAA icon
390
STAAR Surgical
STAA
$1.16B
$480K 0.02%
65,000
+4,000
+7% +$27.1K
INSY
391
DELISTED
Insys Therapeutics, Inc.
INSY
$480K 0.02%
30,000
– –
QGENF
392
DELISTED
QIAGEN NV
QGENF
$478K 0.02%
21,400
-3,600
-14% -$80.4K
ACTG icon
393
Acacia Research
ACTG
$450M
$474K 0.02%
+125,000
New +$459K
JWN
394
DELISTED
Nordstrom
JWN
$472K 0.02%
8,258
-22,011
-73% -$1.13M
MACK
395
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$460K 0.02%
6,991
– –
WMGI
396
DELISTED
Wright Medical Group Inc
WMGI
$448K 0.02%
27,000
– –
EW icon
397
PUT
Edwards Lifesciences
EW
$47.6B
$441K 0.02%
+15,000
New +$414K
TGTX icon
398
TG Therapeutics
TGTX
$8.58B
$435K 0.02%
51,000
– –
GNRT
399
CALL
DELISTED
Gener8 Maritime, Inc.
GNRT
$434K 0.02%
+61,500
New +$397K
JOY
400
DELISTED
Joy Global Inc
JOY
$409K 0.02%
+25,427
New +$320K
14 15
16
17 18

Similar funds

SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
BC
Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return

Weiss Multi-Strategy Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, Weiss Multi-Strategy Advisers held 602 positions worth $2.3B, up 59% from $1.45B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Weiss Multi-Strategy Advisers deployed $795M of net new capital in Q1 2016, opening 223 new positions and adding to 122 existing holdings. Its largest new stake was Prologis: 1,000,337 shares worth $44.2M.

By sector, the portfolio is most concentrated in Real Estate at 23% of assets, up from 21% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Validus Hold Ltd, an estimated $11.9M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q1 2016 buy was Prologis: 1,000,337 shares worth $44.2M.
  • Weiss Multi-Strategy Advisers added most to Brandywine Realty Trust in Q1 2016, an estimated $28M increase.
  • Weiss Multi-Strategy Advisers's biggest Q1 2016 reduction was Validus Hold Ltd, cutting an estimated $11.9M.
  • Weiss Multi-Strategy Advisers fully exited Macerich in Q1 2016, selling an estimated $23.4M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 16% of its $2.3B portfolio in Q1 2016.
  • Weiss Multi-Strategy Advisers opened 223 new positions and closed 146 in Q1 2016.
  • Weiss Multi-Strategy Advisers's portfolio value rose 59% quarter-over-quarter to $2.3B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2016, filed 16 May 2016.